Skip to main content

Market Overview

Why Is Qualigen Stock Trading Lower Today?

Why Is Qualigen Stock Trading Lower Today?
  • Qualigen Therapeutics Inc (NASDAQ: QLGN) shares are ticking lower as the company withdrew the FDA Emergency Use Authorization (EUA) application for its FastPack SARS-CoV-2 IgG diagnostic test for COVID-19 antibodies.
  • According to the SEC filing, the EUA was submitted in June last year, and now the company believes it is no longer viable to launch the test.
  • During the nine months during which the emergency application was with the FDA, alternative tests and testing practices have taken hold, triggering the withdrawal.
  • Price Action: QLGN shares are trading 16.9% lower at $2.16 in the premarket session on the last check Monday.

Related Articles (QLGN)

View Comments and Join the Discussion!

Posted-In: Briefs Covid-19Biotech News Penny Stocks Health Care FDA General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at